Results 21 to 30 of about 367,035 (204)

Angiotensin receptor blockers might be protective against hepatic steatosis after liver transplantation

BMC Gastroenterology, 2023
Background Hepatic steatosis is an increasing complication in liver transplant recipients. Currently, there is no pharmacologic therapy for treatment of hepatic steatosis after liver transplantation. The aim of this study was to determine the association
Ahad Eshraghian, Alireza Taghavi, Hamed Nikoupour, Saman Nikeghbalian, Seyed Ali Malek-Hosseini   +4 more
doaj   +1 more source

Hepatitis B and concomitant hepatic steatosis [PDF]

Journal of Thoracic Disease, 2017
Hepatic steatosis is becoming more common in Asia with prevalence becoming as common as Western countries. Concomitant Hepatitis B and hepatic steatosis is increasingly encountered in clinical practice. The interaction between the two concomitant conditions at both molecular level and clinical outcome remains to be explored. The present review is aimed
Chong Teik, Lim, Rajneesh, Kumar
openaire   +2 more sources

Insomnia Promotes Hepatic Steatosis in Rats Possibly by Mediating Sympathetic Overactivation

Frontiers in Physiology, 2021
Background: Insomnia is a widespread problem that can lead to the occurrence of other diseases and correlates closely with sympathetic nerve hyperactivation. Obesity-induced hepatic steatosis is mediated by sympathetic overactivation. However, it remains
Zongding Wang, Zongding Wang, Xiaoyan Liang, Xiaoyan Liang, Yanmei Lu, Yanmei Lu, Tiemin Jiang, Tiemin Jiang, Tuerganaili Aji, Tuerganaili Aji, Kalibixiati Aimulajiang, Huaxin Sun, Huaxin Sun, Ling Zhang, Ling Zhang, Xianhui Zhou, Xianhui Zhou, Baopeng Tang, Baopeng Tang, Hao Wen, Hao Wen   +20 more
doaj   +1 more source

Insulin sensitisers in the treatment of non-alcoholic fatty liver disease : a systematic review [PDF]

, 2011
Non-alcoholic fatty liver disease (NAFLD) is closely linked with obesity and the prevalence of NAFLD is about 17% to 33% in the Western world. There is a strong association of NAFLD with insulin resistance and, hence, insulin sensitisers have been tried.
C Clar, Henderson, R., Gurung, T., N Waugh, N Sattar, N Ghouri, Clar, C., Sattar, Naveed, Sattar, N., Fraser, A., T Gurung, Gurung, T. (Tara), D Shyangdan, A Fraser, Shyangdan, D., D Preiss, Waugh, Norman, Shyangdan, D. (Deepson), R Henderson, Ghouri, N., Preiss, D., Waugh, N.   +21 more
core   +1 more source

Impact of Hepatic Steatosis on the Antiviral Effects of PEG-IFNα-2a in Patients with Chronic Hepatitis B and the Associated Mechanism

Gastroenterology Research and Practice, 2020
Objective. To investigate the risk factors for hepatic steatosis in chronic hepatitis B (CHB), to determine its correlation with liver necroinflammation and fibrosis and response to peginterferon alpha-2a (PEG-IFNα-2a) antiviral therapy, and to explore ...
Huiqing Liang, Yaoyu Liu, Xiaoqian Jiang, Xiaoting Zheng, Jinmo Tang, Jiaen Yang, Hongli Zhuang, Penghua Lai, Li Peng, Zhenying Guo, Shanshan Cai, Dan Luo, Lingxia Xu, Qianguo Mao, Shaodong Chen   +14 more
doaj   +1 more source

Hepatic Steatosis Is Associated with High White Blood Cell and Platelet Counts

Biomedicines, 2022
The incidence of hepatic steatosis is increasing globally, and it is important to identify those at risk to prevent comorbidities. Complete blood count is a simple, convenient, and inexpensive laboratory examination which can be used to obtain white ...
Yu-Lin Chao, Pei-Yu Wu, Jiun-Chi Huang, Yi-Wen Chiu, Jia-Jung Lee, Szu-Chia Chen, Jer-Ming Chang, Shang-Jyh Hwang, Hung-Chun Chen   +8 more
doaj   +1 more source

Molecular mechanisms of insulin resistance in chronic liver disease [PDF]

, 2008
The work presented here analyses the role of PP2A in the dysregulation of glucose metabolism in the setting of chronic hepatitis C. We propose a new model for virus induced insulin resistance development through the overexpression of PP2A in the liver ...
Bernsmeier, Christine
core   +1 more source

Anthelmintics nitazoxanide protects against experimental hyperlipidemia and hepatic steatosis in hamsters and mice

Acta Pharmaceutica Sinica B, 2022
Lipid metabolism disorders contribute to hyperlipidemia and hepatic steatosis. It is ideal to develop drugs simultaneous improving both hyperlipidemia and hepatic steatosis.
Fengfeng Li, Man Jiang, Minghui Ma, Xuyang Chen, Yidan Zhang, Yixin Zhang, Yuanyuan Yu, Yunfeng Cui, Jiahui Chen, Hui Zhao, Zhijie Sun, Deli Dong   +11 more
doaj   +1 more source

Infection with the hepatitis C virus causes viral genotype-specific differences in cholesterol metabolism and hepatic steatosis [PDF]

, 2022
Background: Lipids play essential roles in the hepatitis C virus (HCV) life cycle and patients with chronic HCV infection display disordered lipid metabolism which resolves following successful anti-viral therapy. It has been proposed that HCV genotype 3
Taylor-Robinson, Simon D., Neely, D, Taylor-Robinson, Simon, Felmlee, Daniel J., Shawa, I.T, Felmlee, D.J, Taylor-Robinson, S.D, Bridge, S.H, Thomas, E. Louise, Bridge, Simon H., Sheridan, David A., Bridge, Simon H, Holmes, Elaine, Sheridan, David, Cobbold, J.F, Bridge, Simon, Thomas, E.L, Neely, Dermot, Bassendine, M.F, Cobbold, Jeremy F., Cobbold, Jeremy, Shawa, Isaac Thom, Bassendine, Margaret F, Sheridan, D.A, Shawa, Isaac, Thomas, E Louise, Felmlee, Daniel J, Bassendine, Margaret F., Holmes, E   +28 more
core   +3 more sources

Prospective association between adherence to the Mediterranean diet and hepatic steatosis: the Swiss CoLaus cohort study

BMJ Open, 2020
Objective The Mediterranean diet has been promoted as a healthy dietary pattern, but whether the Mediterranean diet may help to prevent hepatic steatosis is not clear.
Pedro Marques-Vidal, Fumiaki Imamura, Saman Khalatbari-Soltani, Nita G. Forouhi   +3 more
doaj   +1 more source